Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2012

01-03-2012 | Original Article

Metallic or Plastic Stent for Bile Duct Obstruction in Ampullary Cancer?

Authors: Su Bum Park, Hyung Wook Kim, Dae Hwan Kang, Cheol Woong Choi, Je Ho Ryu, Chong Woo Chu, Soo Yong Lee, Young Il Jeong, Hye Ju Yeo, Eun Jung Kim

Published in: Digestive Diseases and Sciences | Issue 3/2012

Login to get access

Abstract

Background and Aims

Although ampullary cancer is a relatively uncommon malignancy, it is frequently associated with biliary obstruction. Endoscopic biliary drainage is regarded as a palliative treatment of choice for patients with inoperable ampullary cancer. However, there are no data concerning choice of stent in this patient population. The objective of this study was to compare the efficacy of metallic and plastic stents for biliary obstruction in patients with ampullary cancer.

Methods

Thirty-seven patients (15 men and 22 women; median age 74.7 years) with ampullary cancer treated with endoscopic biliary drainage were enrolled. Metallic and two plastic stents were placed in 17 and 20 patients, respectively. Clinical success, stent patency, and stent malfunction were evaluated.

Results

Clinical success was achieved in all patients (100%). The median period of stent patency was 132.7 days in the metallic stent group and 128.5 days in the plastic stent group (P > 0.05). Stent malfunctions developed in 17 and 19 patients in the metallic and plastic stent groups, respectively. Stent occlusion occurred in 15 (88.2%) and 15 (75%) patients and stent migration occurred in two (11.8%) and four (20%) patients in the metallic and plastic stent groups, respectively.

Conclusions

Endoscopic biliary drainage using metallic or plastic stents is effective for initial endoscopic palliation in patients with obstructive jaundice because of ampullary cancer. Although metallic and plastic stents had similar clinical effect, it seems reasonable to choose two plastic stents as the first option in patients with ampullary cancer considering the cost-effectiveness.
Literature
1.
go back to reference Conlon KC. Carcinoma of the ampulla of vater: a distinct disease entity? Ann Surg Oncol. 2003;10:1136–1137.PubMedCrossRef Conlon KC. Carcinoma of the ampulla of vater: a distinct disease entity? Ann Surg Oncol. 2003;10:1136–1137.PubMedCrossRef
2.
go back to reference Talamini MA, Moesinger RC, Pitt HA, et al. Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg. 1997;225:590–599. Discussion 599–600.PubMedCrossRef Talamini MA, Moesinger RC, Pitt HA, et al. Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg. 1997;225:590–599. Discussion 599–600.PubMedCrossRef
3.
go back to reference Albores-Saavedra J, Schwartz AM, Batich K, Henson DE. Cancers of the ampulla of vater: demographics, morphology, and survival based on 5, 625 cases from the SEER program. J Surg Oncol. 2009;100:598–605.PubMedCrossRef Albores-Saavedra J, Schwartz AM, Batich K, Henson DE. Cancers of the ampulla of vater: demographics, morphology, and survival based on 5, 625 cases from the SEER program. J Surg Oncol. 2009;100:598–605.PubMedCrossRef
4.
go back to reference Qiao QL, Zhao YG, Ye ML, et al. Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection. World J Surg. 2007;31:137–143. Discussion 144–146.PubMedCrossRef Qiao QL, Zhao YG, Ye ML, et al. Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection. World J Surg. 2007;31:137–143. Discussion 144–146.PubMedCrossRef
5.
go back to reference Sivak MV. Clinical and endoscopic aspects of tumors of the ampulla of Vater. Endoscopy. 1988;20:211–217.PubMedCrossRef Sivak MV. Clinical and endoscopic aspects of tumors of the ampulla of Vater. Endoscopy. 1988;20:211–217.PubMedCrossRef
6.
go back to reference Morris-Stiff G, Alabraba E, Tan YM, et al. Assessment of survival advantage in ampullary carcinoma in relation to tumour biology and morphology. Eur J Surg Oncol. 2009;35:746–750.PubMedCrossRef Morris-Stiff G, Alabraba E, Tan YM, et al. Assessment of survival advantage in ampullary carcinoma in relation to tumour biology and morphology. Eur J Surg Oncol. 2009;35:746–750.PubMedCrossRef
7.
go back to reference Woo SM, Ryu JK, Lee SH, et al. Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma. Ann Surg Oncol. 2007;14:3195–3201.PubMedCrossRef Woo SM, Ryu JK, Lee SH, et al. Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma. Ann Surg Oncol. 2007;14:3195–3201.PubMedCrossRef
8.
go back to reference Sarmiento JM, Nagomey DM, Sarr MG, Farnell MB. Periampullary cancers: are there differences? Surg Clin North Am. 2001;81:543–555.PubMedCrossRef Sarmiento JM, Nagomey DM, Sarr MG, Farnell MB. Periampullary cancers: are there differences? Surg Clin North Am. 2001;81:543–555.PubMedCrossRef
10.
go back to reference McLean GK, Burke DR. Role of endoprostheses in the management of malignant biliary obstruction. Radiology. 1989;170:961–967.PubMed McLean GK, Burke DR. Role of endoprostheses in the management of malignant biliary obstruction. Radiology. 1989;170:961–967.PubMed
11.
go back to reference Adler DG, Baron TH, Davila RE, et al. ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc. 2005;62:1–8.PubMedCrossRef Adler DG, Baron TH, Davila RE, et al. ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc. 2005;62:1–8.PubMedCrossRef
12.
go back to reference Speer AG, Cotton PB, Russell RC, et al. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet. 1987;2:57–62.PubMedCrossRef Speer AG, Cotton PB, Russell RC, et al. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet. 1987;2:57–62.PubMedCrossRef
13.
go back to reference Prat F, Chapat O, Ducot B, et al. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc. 1998;47:1–7.PubMedCrossRef Prat F, Chapat O, Ducot B, et al. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc. 1998;47:1–7.PubMedCrossRef
14.
go back to reference Hammarstrom LE. Role of palliative endoscopic drainage in patients with malignant biliary obstruction. Dig Surg. 2005;22:295–304. discussion 305.PubMedCrossRef Hammarstrom LE. Role of palliative endoscopic drainage in patients with malignant biliary obstruction. Dig Surg. 2005;22:295–304. discussion 305.PubMedCrossRef
15.
go back to reference Cotton PB. Duodenoscopic placement of biliary prostheses to relieve malignant obstructive jaundice. Br J Surg. 1982;69:501–503.PubMedCrossRef Cotton PB. Duodenoscopic placement of biliary prostheses to relieve malignant obstructive jaundice. Br J Surg. 1982;69:501–503.PubMedCrossRef
16.
go back to reference Huibregtse K, Haverkamp HJ, Tytgat GN. Transpapillary positioning of a large 3.2 mm biliary endoprosthesis. Endoscopy. 1981;13:217–219.PubMedCrossRef Huibregtse K, Haverkamp HJ, Tytgat GN. Transpapillary positioning of a large 3.2 mm biliary endoprosthesis. Endoscopy. 1981;13:217–219.PubMedCrossRef
17.
go back to reference Zimmon DS, Chang J, Clemett AR. Advances in the management of bile duct obstruction: percutaneous transhepatic cholangiography and endoscopic retrograde cholangiopancreatography. Med Clin North Am. 1979;63:593–609.PubMed Zimmon DS, Chang J, Clemett AR. Advances in the management of bile duct obstruction: percutaneous transhepatic cholangiography and endoscopic retrograde cholangiopancreatography. Med Clin North Am. 1979;63:593–609.PubMed
18.
go back to reference Cairns SR, Dias L, Cotton PB, Salmon PR, Russell RC. Additional endoscopic procedures instead of urgent surgery for retained common bile duct stones. Gut. 1989;30:535–540.PubMedCrossRef Cairns SR, Dias L, Cotton PB, Salmon PR, Russell RC. Additional endoscopic procedures instead of urgent surgery for retained common bile duct stones. Gut. 1989;30:535–540.PubMedCrossRef
19.
go back to reference Weber A, Mittermeyer T, Wagenpfeil S, Schmid RM, Prinz C. Self-expanding metal stents versus polyethylene stents for palliative treatment in patients with advanced pancreatic cancer. Pancreas. 2009;38:e7–e12.PubMedCrossRef Weber A, Mittermeyer T, Wagenpfeil S, Schmid RM, Prinz C. Self-expanding metal stents versus polyethylene stents for palliative treatment in patients with advanced pancreatic cancer. Pancreas. 2009;38:e7–e12.PubMedCrossRef
20.
go back to reference Lammer J, Hausegger KA, Fluckiger F, et al. Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents. Radiology. 1996;201:167–172.PubMed Lammer J, Hausegger KA, Fluckiger F, et al. Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents. Radiology. 1996;201:167–172.PubMed
21.
go back to reference Kullman E, Frozanpor F, Soderlund C, et al. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc. 2010;72:924–926.CrossRef Kullman E, Frozanpor F, Soderlund C, et al. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc. 2010;72:924–926.CrossRef
22.
go back to reference Johanson JF, Schmalz MJ, Geenen JE. Incidence and risk factors for biliary and pancreatic stent migration. Gastrointest Endosc. 1992;38:341–346.PubMedCrossRef Johanson JF, Schmalz MJ, Geenen JE. Incidence and risk factors for biliary and pancreatic stent migration. Gastrointest Endosc. 1992;38:341–346.PubMedCrossRef
23.
go back to reference Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut. 2005;54:v1–v16. Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut. 2005;54:v1–v16.
Metadata
Title
Metallic or Plastic Stent for Bile Duct Obstruction in Ampullary Cancer?
Authors
Su Bum Park
Hyung Wook Kim
Dae Hwan Kang
Cheol Woong Choi
Je Ho Ryu
Chong Woo Chu
Soo Yong Lee
Young Il Jeong
Hye Ju Yeo
Eun Jung Kim
Publication date
01-03-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 3/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1909-2

Other articles of this Issue 3/2012

Digestive Diseases and Sciences 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.